These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2. Kelly GS Altern Med Rev; 2010 Dec; 15(4):313-28. PubMed ID: 21194247 [TBL] [Abstract][Full Text] [Related]
6. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 1. Kelly G Altern Med Rev; 2010 Sep; 15(3):245-63. PubMed ID: 21155626 [TBL] [Abstract][Full Text] [Related]
8. The neurobiology of sirtuins and their role in neurodegeneration. Donmez G Trends Pharmacol Sci; 2012 Sep; 33(9):494-501. PubMed ID: 22749331 [TBL] [Abstract][Full Text] [Related]
9. Slowing ageing by design: the rise of NAD Bonkowski MS; Sinclair DA Nat Rev Mol Cell Biol; 2016 Nov; 17(11):679-690. PubMed ID: 27552971 [TBL] [Abstract][Full Text] [Related]
10. Sirtuins: novel targets for metabolic disease in drug development. Jiang WJ Biochem Biophys Res Commun; 2008 Aug; 373(3):341-4. PubMed ID: 18577374 [TBL] [Abstract][Full Text] [Related]
11. After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders. Huber K; Superti-Furga G Bioorg Med Chem; 2011 Jun; 19(12):3616-24. PubMed ID: 21306906 [TBL] [Abstract][Full Text] [Related]
12. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. Pacholec M; Bleasdale JE; Chrunyk B; Cunningham D; Flynn D; Garofalo RS; Griffith D; Griffor M; Loulakis P; Pabst B; Qiu X; Stockman B; Thanabal V; Varghese A; Ward J; Withka J; Ahn K J Biol Chem; 2010 Mar; 285(11):8340-51. PubMed ID: 20061378 [TBL] [Abstract][Full Text] [Related]